Results from the Phase 3 clinical trial of NurOwn

Co-presented by Dr Merit Cudkowicz, from Harvard Medical School and Massachusetts General Hospital, and Dr Ralph Kern from BrainStorm Cell Therapeutics, this presentation discussed the keenly awaited results of the Phase 3 clinical trial of NurOwn.

It’s the most ‘science-y’ time of the year…

It’s that time of year again. With just a week to go until the 31st International Symposium on ALS/MND, we thought we’d bring you an update on everything we’ve been doing to make sure we can still present the biggest scientific conference on ALS/MND in the world.